Evolution of pleural cancers and malignant pleural mesothelioma incidence in France between 1980 and 2005

International Journal of Cancer

Volumn 126, Issue 1, 2010, Pages 232-238

  Le Stang, N ^a,b   Belot, A ^c,d,e,f   Gilg Soit Ilg, A ^a,f   Rolland, P ^a,f   Astoul, P ^g   Bara, S ^h   Brochard, P ^i,j   Danzon, A ^h   Delafosse, P ^h   Grosclaude, P ^h   Guizard, A V ^h   Imbernon, E ^f   Lapotre Ledoux B ^h   Ligier, K ^h   Molinie F ^h   Pairon, J C ^k,l,m   Sauleau, E A ^h   Tretarre B ^h   Velten, M ^h   Bossard, N ^c,d,e   Goldberg, M ^f   Launoy, G ^a,b   Galateau Salle F ^a,b   more..

^a CAEN UNIVERSITY HOSPITAL   (France)

^b INSERM   (France)

^c HOSPICES CIVILS DE LYON   (France)

^d UNIVERSITÉ LYON 1   (France)

^e LABORATOIRE DE BIOMÉTRIE ET BIOLOGIE EVOLUTIVE   (France)

^f INSTITUT DE VEILLE SANITAIRE   (France)

^g HÔPITAL SAINTE MARGUERITE   (France)

^h UNIVERSITÉ DE TOULOUSE   (France)

ⁱ UNIVERSITÉ DE BORDEAUX   (France)

^j BORDEAUX UNIVERSITY HOSPITAL   (France)

^k INSERM U955   (France)

^l FACULTÉ DE MÉDECINE   (France)

^m CENTRE HOSPITALIER INTERCOMMUNAL DE CRÉTEIL   (France)

more..

Author keywords

Cancer registry; Incidence; Malignant pleural mesothelioma; Pleural cancers; PNSM; Time trends

Indexed keywords

ASBESTOS;

ARTICLE; CANCER INCIDENCE; CANCER REGISTRY; CONTROLLED STUDY; FEMALE; FRANCE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; PLEURA CANCER; PLEURA MESOTHELIOMA; PRIORITY JOURNAL; SEX DIFFERENTIATION;

EID: 73449109540     PISSN: 00207136     EISSN: 10970215     Source Type: Journal    
DOI: 10.1002/ijc.24711     Document Type: Article

References (31)

1. Bianchi C, Bianchi T. Malignant mesothelioma: global incidence and relationship with asbestos. Ind Health 2007;45:379-87.
2. Peto J, Decarli A, La Vecchia C, Levi F, Negri E. The European mesothelioma epidemic. Br J Cancer 1999;79:666-72.
3. Mak V, Davies E, Putcha V, Choodari-Oskooei B, Møller H. The epidemiology and treatment of mesothelioma in South East England 1985-2002. Thorax 2008;63:160-6.
4. Ulvestad B, Kjaerheim K, Møller B, Andersen A. Incidence trends ofmesothelioma in Norway, 1965-1999. Int J Cancer 2003;107:94-8.
5. Marinaccio A, Montanaro F, Mastrantonio M, Uccelli R, Altavista P, Nesti M, Seniori Costantini A, Gorini G. Predictions of mortality from pleural mesothelioma in Italy: a model based on asbestos consumption figures supports results from age-period-cohort models. Int J Cancer 2005;115:142-7.
6. Marrett LD, Ellison LF, Dryer D. Canadian cancer statistics at a glance: mesothelioma. CMAJ 2008;178:677-8.
7. Kanazawa N, Ioka A, Tsukuma H, Ajiki W, Oshima A. Incidence and survival of mesothelioma in Osaka, Japan. Jpn J Clin Oncol 2006;36:254-7.
8. Segura O, Burdorf A, Looman C. Update of predictions of mortality from pleural mesothelioma in the Nederlands. Occup Environ Med 2003;60:50-5.
9. Burdorf A, Järvholm B, Englund A. Explaining differences in incidence rates of pleural mesothelioma between Sweden and The Netherlands. Int J Cancer 2005;113:298-301.
10. Leigh J, Davidson P, Hendrie L, Berry D. Malignant mesothelioma in Australia, 1945-2000. Am J Ind Med 2002;41:188-201.
11. Clements M, Berry G, Shi J, Ware S, Yates D, Johnson A. Projected mesothelioma incidence in men in New South Wales. Occup Environ Med 2007;64:747-52.
12. Hodgson JT, McElvenny DM, Darnton AJ, Price MJ, Peto J. The expected burden of mesothelioma mortality in Great Britain from 2002 to 2050. Br J Cancer 2005;92:587-93.
13. Weill H, Hughes J, Churg A. Changing trends in US mesothelioma incidence. Occup Environ Med 2005;62:270-1.
14. Price B, Ware A. mesothelioma trends in United States: an update based on surveillance. Epidemiology, and end results program. Data for 1973 through 2003. Am J Epidemiol 2004;159:107-12.
15. Price B. Analysis of Current Trends in United States Mesothelioma Incidence. Am J Epidemiol 1997;145:211-8.
16. Järvholm B, Englund A, Albin M. Pleural mesothelioma in Sweden: an analysis of the incidence according to the use of asbestos. Occup Environ Med 1999;56:110-3.
17. Hemminki K, Li X. Mesothelioma incidence seems to have levelled off in Sweden. Int J Cancer 2003;103:145-6.
18. Karjalainen A, Pukkala E, Mattson K, Tammilehto L, Vainio H. Trends in mesothelioma incidence and occupational mesotheliomas in Finland in 1960-1995. Scand J Work Environ Health 1997;23:266-70.
19. Remontet L, Esteve J, Bouvier AM, Grosclaude P, Launoy G, Ménégoz F, Exbrayat C, Tretare B, Carli PM, Guizard AV, Troussard X, Bercelli P, et al. Cancer incidence and mortality in France over the period 1978-2000. Rev Epidemiol Sante Publique 2003;51:3-30.
20. Ilg AG, Bignon J, Valleron AJ. Estimation of the past and future burden of mortality from mesothelioma in France. Occup Environ Med 1998;55:760-5.
21. Banaei A, Auvert B, Goldberg M, Gueguen A, Luce D, Goldberg S. Future trends in mortality of French men from mesothelioma. Occup Environ Med 2000;57:488-94.
22. Goldberg M, Imbernon E, Rolland P, Gilg Soit Ilg A, Savès M, de Quillacq A, Frenay C, Chamming's S, Arveux P, Boutin C, Launoy G, Pairon JC, et al. The French National Mesothelioma Surveillance Program. Occup Environ Med 2006;63:390-5.
23. Belot A, Grosclaude P, Bossard N, Jougla E, Benhamou E, Delafosse P, Guizard AV, Molinié F, Danzon A, Bara S, Bouvier AM, Trétarre B, et al. Cancer incidence and mortality in France over the period 1980-2005. Rev Epidemiol Sante Publique 2008;56:159-75.
24. Clayton D, Schifflers E. Models for temporal variation in cancer rates. I: Age-Period and Age-Cohort models. Stat Med 1987;6:449-67.
25. Clayton D, Schifflers E. Models for temporal variation in cancer rates. II. Age-Period-Cohort models. Stat Med 1987;6:469-81.
26. Estève J, Benhamou E, Raymond L. Statistical methods in cancer research. IV. Descriptive epidemiology. Lyon: International Agency for Research on Cancer, 1994. IARC Scientific Publications 128.
27. Hodgson JT, Darnton A. The quantitative risks of mesothelioma and lung cancer in relation to asbestos exposure. Ann Occup Hyg 2000;44:565-601.
28. Price B, Wilson R. Trends in mesothelioma incidence and asbestos exposure evaluation. In:Nolan RP, Langer AM, Ross M, Wicks FJ, Martin RF, eds. Health effects of chrysotile-asbestos: contribution of science to risk management decisions. Canadian Mineralogist Special Publication 5, 2001, pp. 1-304.
29. McDonald JC, McDonald AD. The epidemiology of mesothelioma in historical context. Eur Respir J 1996;9:1932-42.
30. Goldberg M, Banaei A, Goldberg S, Auvert B, Luce D, Guéguen A. Past occupational exposure to asbestos among men in France. Scand J Work Environ Health 2000;26:52-61.
31. Virta RL. Worldwide asbestos supply and consumption trends from 1900 through 2003: U.S. Geological Survey Circular 1298. Virginia:U.S. Geological Survey, 2006. 80. Available only online.